Ubs Group Ag Biolife Solutions Inc Transaction History
Ubs Group Ag
- $452 Billion
- Q3 2024
A detailed history of Ubs Group Ag transactions in Biolife Solutions Inc stock. As of the latest transaction made, Ubs Group Ag holds 14,930 shares of BLFS stock, worth $413,411. This represents 0.0% of its overall portfolio holdings.
Number of Shares
14,930
Previous 14,585
2.37%
Holding current value
$413,411
Previous $312,000
19.55%
% of portfolio
0.0%
Previous 0.0%
Shares
29 transactions
Others Institutions Holding BLFS
# of Institutions
197Shares Held
44.8MCall Options Held
8.2KPut Options Held
4K-
Casdin Capital, LLC New York, NY8.71MShares$241 Million16.93% of portfolio
-
Black Rock Inc. New York, NY5.49MShares$152 Million0.0% of portfolio
-
Invesco Ltd. Atlanta, GA3.2MShares$88.7 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.85MShares$78.9 Million0.0% of portfolio
-
Fred Alger Management, LLC New York, NY1.58MShares$43.7 Million0.2% of portfolio
About BIOLIFE SOLUTIONS INC
- Ticker BLFS
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 42,684,400
- Market Cap $1.18B
- Description
- BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene therapy industry in the United States, Canada, Europe, the Middle East, Africa, and internationally. The company's products are used in the basic and applied research, and commercial manufacturing of biologic-based therapies. It of...